Efficient inactivation ofBurkholderia pseudomalleiorFrancisella tularensisin infected cells for safe removal from biosafety level 3 containment laboratories-Reference-Cited by-同舟云学术

Efficient inactivation ofBurkholderia pseudomalleiorFrancisella tularensisin infected cells for safe removal from biosafety level 3 containment laboratories

Published:2014-02-18 Issue:2 Volume:71 Page:276-281
ISSN:2049-632X
Container-title:Pathogens and Disease
language:en
Short-container-title:Pathogens Disease

Author:

Emery Felicia D.¹,Stabenow Jennifer M.²,Miller Mark A.¹

Affiliation:

1. The University of Tennessee Health Science Center; Memphis TN USA

2. The University of Tennessee Health Science Center; Regional Biocontainment Laboratory; Memphis TN USA

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine,Immunology and Allergy

Reference21 articles.

1. Rapid and biologically safe procedures for the evaluation of antigen-specific T cell response to microbial pathogens that may be used in the BSL-3 and BSL-4 environment;Agrati;Appl Biosaf,2008

2. Recovery of infectious human immunodeficiency virus from cells treated with 1% paraformaldehyde;Aloisio;J Immunol Methods,1990

3. Applications of flow cytometry to clinical microbiology;Alvarez-Barrientos;Clin Microbiol Rev,2000

4. Waterborne outbreak of tularemia associated with crayfish fishing;Anda;Emerg Infect Dis,2001

5. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion;Baron;Infect Immun,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective methods for the inactivation of Francisella tularensis;PLOS ONE;2019-11-14

2. Rapid Inactivation of Non-Endospore-Forming Bacterial Pathogens by Heat Stabilization is Compatible with Downstream Next-Generation Sequencing;Applied Biosafety;2019-07-15

3. Local application of bacteria improves safety of Salmonella-mediated tumor therapy and retains advantages of systemic infection;Oncotarget;2017-06-07